| Breakdown | TTM | Mar 2025 | Mar 2024 | Mar 2023 | Mar 2022 | Mar 2021 |
|---|---|---|---|---|---|---|
Income Statement | ||||||
| Total Revenue | 67.72B | 66.41B | 57.25B | 61.60B | 55.44B | 39.22B |
| Gross Profit | 10.27B | 10.57B | 9.27B | 10.15B | 10.31B | 6.67B |
| EBITDA | 3.58B | 4.41B | 3.94B | 4.62B | 5.10B | 2.82B |
| Net Income | 1.84B | 2.24B | 1.92B | 2.74B | 2.96B | 1.28B |
Balance Sheet | ||||||
| Total Assets | 43.21B | 44.88B | 42.15B | 43.15B | 41.78B | 33.19B |
| Cash, Cash Equivalents and Short-Term Investments | 3.69B | 5.47B | 5.70B | 6.04B | 8.67B | 5.92B |
| Total Debt | 36.16M | 75.04M | 70.22M | 350.82M | 0.00 | 0.00 |
| Total Liabilities | 19.96B | 21.12B | 19.67B | 21.92B | 21.95B | 15.32B |
| Stockholders Equity | 23.26B | 23.76B | 22.48B | 21.21B | 19.83B | 17.87B |
Cash Flow | ||||||
| Free Cash Flow | 0.00 | 1.10B | 979.20M | -374.37M | 3.89B | 1.58B |
| Operating Cash Flow | 0.00 | 1.78B | 2.53B | 321.45M | 4.56B | 2.13B |
| Investing Cash Flow | 0.00 | -893.35M | -1.61B | -1.55B | -677.06M | -553.00M |
| Financing Cash Flow | 0.00 | -1.13B | -1.33B | -1.42B | -1.20B | -657.42M |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
80 Outperform | ¥14.27B | 8.89 | ― | 4.93% | 3.19% | 1.83% | |
79 Outperform | ¥28.17B | 8.82 | ― | 2.96% | 9.16% | -21.26% | |
78 Outperform | ¥10.52B | 7.66 | ― | 3.48% | 0.24% | 20.23% | |
63 Neutral | $10.79B | 15.43 | 7.44% | 2.01% | 2.89% | -14.66% | |
63 Neutral | ¥15.69B | 4.33 | ― | 2.87% | 2.38% | -5.80% | |
54 Neutral | ¥22.21B | 3.53 | ― | 4.33% | 5.12% | ― | |
52 Neutral | ¥35.26B | 11.14 | ― | 4.92% | -7.06% | -31.96% |